YA II PN, Ltd. 13D and 13G filings for InMed Pharmaceuticals Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-12-18 08:05 am Purchase | 2024-12-13 | 13G | InMed Pharmaceuticals Inc. INM | YA II PN, Ltd. | 80,372 9.990% | 80,372 (New Position) | Filing |